You are here

Article info

Article menu

Download PDFPDF

XML
Recent advances in basic science
Protease inhibition as new therapeutic strategy for GI diseases

Authors

  • Nathalie Vergnolle Inserm, U1220, Toulouse, France Université de Toulouse, Université Paul Sabatier, Institut de Recherche en Santé Digestive (IRSD), Toulouse, France Inra, U1416, Toulouse, France Ecole Nationale Vétérinaire de Toulouse (ENVT), France Department of Pharmacology and Physiology, University of Calgary, Calgary, Alberta, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nathalie Vergnolle, INSERM, UMR-1220, IRSD, Place du Dr. Baylac, CHU Purpan, CS 60039, Toulouse 31024, Cedex 3, France; nathalie.vergnolle{at}inserm.fr
View Full Text

Citation

Vergnolle N
Protease inhibition as new therapeutic strategy for GI diseases
Gut 2016;65:1215-1224.

Publication history

  • Received April 3, 2015
  • Revised February 5, 2016
  • Accepted February 12, 2016
  • First published April 12, 2016.
Online issue publication 
June 03, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/